These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21385809)

  • 21. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Glueck CJ; Pranikoff J; Aregawi D; Wang P
    Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin in polycystic ovary syndrome.
    Fisken RA
    N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
    [No Abstract]   [Full Text] [Related]  

  • 24. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Franks S
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Cataldo NA; Abbasi F; McLaughlin TL; Basina M; Fechner PY; Giudice LC; Reaven GM
    Hum Reprod; 2006 Jan; 21(1):109-20. PubMed ID: 16155076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS).
    Wassell J; Michail M; Soliman N; Wardle PG
    Clin Lab; 2011; 57(1-2):95-8. PubMed ID: 21391472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polycystic ovary syndrome (PCOS)].
    Thaler CJ
    MMW Fortschr Med; 2007 May; 149(21):33-5. PubMed ID: 17668731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin in polycystic ovary syndrome.
    Targher G; Lippi G; Moghetti P
    N Engl J Med; 2008 Apr; 358(17):1867; author reply 1868. PubMed ID: 18437728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contemporary diagnostic criteria for polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2004; 43(3):55-8. PubMed ID: 15341262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
    Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin in polycystic ovary syndrome.
    Mascitelli L; Pezzetta F; Goldstein MR
    N Engl J Med; 2008 Apr; 358(17):1867-8; author reply 1868. PubMed ID: 18437729
    [No Abstract]   [Full Text] [Related]  

  • 34. Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
    Kebapcilar L; Kebapcilar AG; Bilgir O; Taner CE; Bozkaya G; Yildiz Y; Sari I
    Gynecol Endocrinol; 2011 Feb; 27(2):91-5. PubMed ID: 20528207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of infertility in the polycystic ovary syndrome.
    Geberhiwot T; Jones AF
    N Engl J Med; 2007 May; 356(19):2000; author reply 1999-2001. PubMed ID: 17506158
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J;
    Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of metformin in pediatric age.
    Brufani C; Fintini D; Nobili V; Patera PI; Cappa M; Brufani M
    Pediatr Diabetes; 2011 Sep; 12(6):580-8. PubMed ID: 21366813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.